Prøve GULL - Gratis
Public criticism of predecessors
Business Standard
|October 18, 2025
Leadership is complex.
Trainers draw lessons from other leaders’ experiences and convert them into memorable rules — but they are mere mantras. For every rule articulated, there is an exception. For example, Steve Jobs of Apple fame was a Stanford dropout, wore turtlenecks, and was rude to colleagues. Aspiring entrepreneurs should not emulate these. Elizabeth Holmes of Theranos tried but is now languishing in federal prison.
Despite this there are best practices.
Every leader learns about how and what to speak publicly about predecessors and present colleagues. In one social-media post recently, I read a view (I thoroughly disagree) that JRD Tata was a fabulous and ethical leader but left a “leaky and unstable umbrella” for Ratan Tata. All leaders hand over unresolved problems to the successor, apart from a good record of accomplishments. What we should think about is public disparaging of the predecessor.
Does public criticism matter? Why would a leader do so? We see this occurrence both in national politics and in companies. Psychology suggests that it may work to some extent in politics but is rarely effective in a corporate setting.
Denne historien er fra October 18, 2025-utgaven av Business Standard.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Business Standard
Business Standard
Hookah served with food in restaurants to be taxed separately
Tobacco-based hookah will attract 40 % GST, while non-tobacco (herbal) hookah will be taxed at 18%
2 mins
March 04, 2026
Business Standard
RMZ aims to double its office portfolio in next five years
Bengaluru-based alternative assets owner RMZ is aiming to double its office portfolio, which currently spans 21 million square feet (msf), in the next five years through a combination of acquisitions and greenfield joint developments (JDs).
1 mins
March 04, 2026
Business Standard
Angels in white: Indian nurses hold the line in the shadow of conflict
“There is no official data regarding the nursing community living abroad.
1 mins
March 04, 2026
Business Standard
Delivering value, returns consistently
Fund outperforms benchmark Nifty 500 TRI and its peers
2 mins
March 04, 2026
Business Standard
'Earlier, almost any IPO could find demand. That phase is over'
After a record-breaking run last year, India’s initial public offering (IPO) market has begun 2026 on a subdued note, with volatility and geopolitical risks tempering investor appetite. But the slowdown does not signal a freeze, says Neha Agarwal, managing director (MD) and head of ECM at JM Financial. Instead, the market is entering a far more selective phase. In an interview with Samie Modak and Khushboo Tiwari in Mumbai, Agarwal outlines why the next cycle will reward quality over quantity and which sectors are best placed to attract capital. Edited excerpts:
3 mins
March 04, 2026
Business Standard
The vision behind Jungle Lodges & Resorts
JLR stands as a pioneering ecotourism model in India, blending conservation, community empowerment and immersive nature experiences while promoting sustainable livelihoods and environmental stewardship
3 mins
March 04, 2026
Business Standard
State simplifies ODOP, MSME approvals
The Rajasthan industries department has overhauled the approval process for the One District, One Product Policy (ODOP) and MSME Policy, with an eye on ease of doing business.
1 mins
March 04, 2026
Business Standard
Salary increments for 2026 likely to be 6-10%
Adecco says expectations cross 10% in high-demand areas such as AI and EVs
3 mins
March 04, 2026
Business Standard
Ensuring safety of 10 mn Indians in Gulf ‘utmost priority’: MEA
India on Tuesday said it raised its “voice clearly in favour of an early end to the conflict” in West Asia, which has evoked “great anxiety” since almost 10 million Indian citizens live and work in the Gulf region.
3 mins
March 04, 2026
Business Standard
Two pharmas, two playbooks
MNCs and Indian drugmakers are diverging to their mutual advantage. How much of a win-win is it?
6 mins
March 04, 2026
Listen
Translate
Change font size
